Greece Launches World’s First National Wildfire Satellite System with OroraTechMUNICH, May 04, 2026 (GLOBE NEWSWIRE) -- OroraTech, the global leader in space-based wildfire intelligence, today announced the successful launch and deployment of the Hellenic Fire System, four dedicated wildfire monitoring satellites for Greece, marking the world’s first national satellite system designed exclusively for wildfire detection and tracking. The satellites were launched with SpaceX via Vandenberg Space Force Base in California.
Core Specialty Announces Mike Powell as General CounselCINCINNATI, May 04, 2026 (GLOBE NEWSWIRE) -- Core Specialty Insurance Holdings, Inc. and its subsidiaries (“Core Specialty” or the “Company”) announced today that Mike Powell has been appointed Executive Vice President and General Counsel effective immediately, replacing Robert Kuzloski. Mr. Kuzloski will be retiring and has served as General Counsel since the company’s recapitalization in November 2020. Core Specialty’s management is grateful for his many contributions and wishes him the very best in the years ahead. Mike will be based in the Company’s Cincinnati, Ohio headquarters.
H2O Innovation Enters the UV Disinfection Market with the Acquisition of bestUVQUEBEC CITY, May 04, 2026 (GLOBE NEWSWIRE) -- H2O Innovation Inc. (“H2O Innovation” or the “Corporation”) is pleased to announce the acquisition of bestUV (“bestUV”), a Dutch manufacturer of ultraviolet (UV) water disinfection systems serving a wide range of applications and markets.
Benchmark Resorts & Hotels Partners with Dress for Success to Launch “Leave a Power Suit Behind” and Champion Women this Mother’s DayThe collection of independent hotels unveils a new program that invites guests at select properties across the nation to pack with purpose, uplift women by leaving behind workplace apparel and accessories
Finacity and MUFG Arrange a 3-Year USD 175 Million Receivables Securitization for TennecoSTAMFORD, Conn., May 04, 2026 (GLOBE NEWSWIRE) -- Finacity Corporation (“Finacity”) a White Oak Global Advisors company, and MUFG Bank, Ltd (“MUFG”) announce that they have successfully launched a trade receivables securitization for Tenneco LLC (“Tenneco”), a global manufacturer and supplier of automotive parts headquartered in the United States.
Scott Drennan Named President and CEO of Otto AerospaceBoard elevates the chief operating officer to lead the company's next chapter of disciplined execution following successful completion of Phantom 3500 preliminary design review
Fate Therapeutics Announces Three Presentations at the 2026 ASGCT Annual Meeting Highlighting Off-the-Shelf CAR T-cell Therapy Pipeline for Cancer and Autoimmune DiseasesSAN DIEGO, May 04, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (
NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a transformative pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune diseases, today announced that data from its off-the-shelf CAR T-cell programs FT819, FT839, and FT836, will be featured at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting to be held in Boston, MA, May 11–15, 2026.
Nexxen and ADvolution Bring Influencer Engagement to Programmatic Political CampaignsNew partnership helps political advertisers activate influencer-aligned audience segments as one in five Americans increasingly turn to social creators for news
Older Americans Month Highlights How Area Agencies on Aging Help Older Adults “Champion Their Health” at HomeWashington, DC, May 04, 2026 (GLOBE NEWSWIRE) -- Every May as a nation, we recognize Older Americans Month, an annual observance that celebrates the contributions and resilience of the 58 million older adults in our country. This year’s theme, Champion Your Health, encourages individuals to take steps—large and small—to support their health and well-being.
CarnoSyn® Brands Expands TriBsyn® Applications Across Beverage, Dairy, and Medical NutritionTriBsyn® enables next-generation wellness solutions in RTD beverages, protein drinks, dairy products, and more
Byline Bank Named a 2026 Best Workplace in Illinois Based on employee survey data, Illinois SHRM and Best Companies Group recognize employers in the state who are committed to strong workplace practices
$4.9 Billion in Losses. 14 Straight Years. SambaSafety’s 2026 Driver Risk Report Reveals Why Commercial Auto Can’t Catch a Break—and What Finally WorksDenver, CO, May 04, 2026 (GLOBE NEWSWIRE) -- The commercial auto market faces unprecedented challenges, and the data clearly shows that these issues are not easing. Since 2015, claims severity has increased by 64%. Thermonuclear verdicts, jury awards exceeding $100 million, were up 81% in a single year. Risky driving behaviors are compounding an already stressed market. The cost of inaction has never been higher. 1
Redwood Services Expands National Footprint With Acquisition of Sierra Platform From SE CapitalThe transaction marks a major strategic deal in residential home services and expands Redwood Services into three new markets
17 Days After Forager’s Proposal, Board Still Has Not Engaged as Stockholder Frustration BuildsBIRMINGHAM, Ala., May 04, 2026 (GLOBE NEWSWIRE) -- Forager Capital Management (“Forager”), the largest stockholder of Repay Holdings Corporation (
NASDAQ: RPAY) (the “Company”), with beneficial ownership of approximately 13% of the issued and outstanding shares, issued the following statement:
Foxx Development Regains Compliance with Nasdaq Minimum Market Value of Listed Securities RequirementIrvine, CA , May 04, 2026 (GLOBE NEWSWIRE) -- Foxx Development Holdings Inc. ("Foxx Development" or the "Company") (Nasdaq: FOXX), a leading provider of consumer electronics and integrated Internet-of-Things (IoT) solutions for retail and institutional clients, today announced that it has received written notification from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") confirming that the Company has regained compliance with Nasdaq Listing Rule 5550(b)(2), and that the related listing matter is now closed.
EOSE Investors Have Opportunity to Lead Eos Energy Enterprises, Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, May 04, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Eos Energy Enterprises, Inc. (“Eos Energy” or “the Company”) (
NASDAQ: EOSE) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Operative Appoints Dang Ly as Chief Product Officer to Accelerate Data-Driven Innovation and GrowthIndustry Veteran Brings Two Decades Of Omnichannel Audience Experiences and Enterprise Data Strategy to Operative's Next Chapter
Curated Digital Health Works; Now There’s a Claims Study to Prove ItIndependent validation of a large U.S. health plan’s claims data shows $1,241 in per-member savings, a $2.42 return on every dollar invested, and meaningful reduction in high-cost utilization
DRVN Investors Have Opportunity to Lead Driven Brands Holdings Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, May 04, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Driven Brands Holdings Inc. (“Driven Brands” or “the Company”) (
NASDAQ: DRVN) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Gyre Therapeutics Completes Acquisition of Cullgen to Create U.S.- and China-based Fully Integrated Biopharmaceutical CompanySAN DIEGO, May 04, 2026 (GLOBE NEWSWIRE) -- Gyre Therapeutics, Inc. (“Gyre”, “Gyre Therapeutics” or the “Company”) (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies across organ systems affected by chronic diseases, today announced the closing of its acquisition of Cullgen Inc. (Cullgen), a privately-held, clinical-stage biopharmaceutical company focused on the discovery and development of targeted protein degrader (TPD) and degrader antibody conjugate (DAC) therapies, in an all-stock transaction valued at approximately $300 million.
INVESTOR REMINDER: Berger Montague Notifies Gossamer Bio, Inc. (NASDAQ: GOSS) Investors of a Class Action Lawsuit and DeadlinePHILADELPHIA, May 04, 2026 (GLOBE NEWSWIRE) -- National plaintiffs’ law firm Berger Montague PC announces a class action lawsuit against Gossamer Bio, Inc. (
NASDAQ: GOSS) (“Gossamer” or the “Company”) on behalf of investors who purchased or acquired Gossamer shares during the period from June 16, 2025 through February 20, 2026 (the “Class Period”).
Reel-Funding Group Launches Multi-Fund Platform to Finance Independent Film SlatesJACKSONVILLE, Fla., May 04, 2026 (GLOBE NEWSWIRE) -- Reel-Funding Group (RFG), a film finance and production company, today announced the launch of a multi-fund investment platform purpose-built to finance and produce independent films through partnerships with established and emerging filmmakers.
Polyrizon Announces U.S. Patent Expansion for Its Intranasal Drug Delivery PlatformRaanana, Israel, May 04, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development-stage biotech company specializing in the development of innovative intranasal hydrogels, today announced the submission of amended claims in its U.S. patent application for its proprietary intranasal drug delivery platform.
NKTR Investors Have Opportunity to Lead Nektar Therapeutics Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, May 04, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Nektar Therapeutics (“Nektar” or “the Company”) (
NASDAQ: NKTR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Atlas Lithium Corporation to Present at the Precious Metals & Critical Minerals Virtual Investor Conference May 5thCompany invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com
Service Robotics Growth Accelerates as Global Demand Fuels Strategic ExpansionAUSTIN, Texas, May 04, 2026 (GLOBE NEWSWIRE) -- AINewsWire Editorial Coverage: Global demand for service robotics is accelerating as industries increasingly turn to automation to address labor shortages, rising costs and operational inefficiencies. According to the International Federation of Robotics, service robot adoption continues to expand worldwide, with hundreds of thousands of units deployed annually and strong growth expected across hospitality, logistics and healthcare sectors. Market forecasts reinforce this trajectory, projecting the global service robotics market to grow from roughly $31 billion in 2026 to more than $131 billion by 2034, reflecting sustained double-digit growth driven by AI and automation adoption. Nightfood Holdings Inc. (OTC: NGTF) (Profile), (dba as TechForce Robotics), is positioning itself at the center of this transformation by focusing on real-world deployment, scalable infrastructure and strategic partnerships that enable global expansion in the AI robotics space. The company is focused on becoming an innovative leader in the robotics segment, aligned with others in the space, including Microsoft Corporation (
NASDAQ: MSFT), ABB Ltd. (OTC: ABBNY), Rockwell Automation Inc. (
NYSE: ROK) and Richtech Robotics Inc. (
NASDAQ: RR).
Alico to Present at the LD Micro Invitational XVIFORT MYERS, Fla., May 04, 2026 (GLOBE NEWSWIRE) -- Alico, Inc. (“Alico” or the “Company”) (Nasdaq: ALCO) today announced that John Kiernan, the Company’s President and Chief Executive Officer, will present and host one-on-one meetings with investors at the LD Micro Invitational XVI Conference, taking place on May 17-19, 2026 in Los Angeles, CA.
Satellogic Expands Global Sales Force with Senior Defense and Intelligence Industry VeteransNEW YORK, May 04, 2026 (GLOBE NEWSWIRE) -- Satellogic, Inc. (
NASDAQ: SATL), a vertically integrated geospatial company delivering high-resolution Earth Observation (EO) at unprecedented scale and economics, today announced the addition of three senior industry veterans to its global sales organization: Matt Clark, Brett Davis, and Jonathan Lee.
Bicara Therapeutics to Report First Quarter 2026 Financial Results and Business Updates on May 11, 2026, at 8:30 AM ETBOSTON, May 04, 2026 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, today announced that it will report first quarter 2026 financial results and business updates before the market opens on Monday, May 11, 2026. Bicara will host a conference call to discuss the financial results and business updates at 8:30 a.m. ET the same day. Individuals may register for the conference call by clicking the link here. Once registered, participants will receive dial-in details and a unique PIN that will allow them to access the call. To access the live webcast, please visit the “Events & Presentations” section within the Investors page on the Bicara website. A replay of the webcast will be available for 30 days following the event.
Newtek Bank, N.A. Customers Now Have the Ability to Receive Instant Payments Through the FedNow® Service and RTP® Network 24/7/365BOCA RATON, Fla., May 04, 2026 (GLOBE NEWSWIRE) -- NewtekOne, Inc. (
NASDAQ: NEWT) (“NewtekOne”) announced that its bank subsidiary, Newtek Bank, N.A. (“Newtek Bank”), now offers its commercial banking customers the capability to receive instant payments through the Federal Reserve’s FedNow® Service and The Clearing House’s RTP® network twenty-four hours a day, seven days a week, 365 days per year.
Liquidia Corporation to Report First Quarter 2026 Financial Results on May 11, 2026MORRISVILLE, N.C., May 04, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (Nasdaq: LQDA), a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challenging respiratory and vascular diseases, announced today that it will report its first quarter 2026 financial results on Monday, May 11, 2026. The company will host a live webcast at 8:30 a.m. Eastern Time to discuss its financial results and provide a corporate update.
Raven Capital Sells Stake in Outback Presents’ Comedy Business to AEG Presents in Milestone TransactionLOS ANGELES, May 04, 2026 (GLOBE NEWSWIRE) -- Raven Capital (“Raven”), an alternative investment firm specializing in asset-based, non-sponsor private credit, today announced that its portfolio company, Outback Presents, has completed the sale of a minority stake in its comedy business to AEG Presents, a leading global sports and live entertainment company.
Higher Prices Sustained Small Business Sales Growth in April, Fiserv Data ShowsFiserv Small Business Index remands steady at 144; year-over-year sales grew +1.1%
Abeona Therapeutics® Announces Date of First Quarter Financial ResultsCLEVELAND, May 04, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it will host a conference call on Wednesday, May 13, 2026 at 8:30 a.m. ET to discuss its financial results for the first quarter of 2026 and corporate progress.
GlobalFoundries accelerates adoption of co-packaged optics for advanced AI data centers with SCALE optical module solutionSCALE CPO solution is the industry’s first OCI MSA capable platform and built with GF’s proven silicon photonics technology
Axe Compute Inc. (NASDAQ: AGPU) CEO Chris Miglino to Appear on Schwab Network May 4 and Cheddar May 6Following the Company's recently announced $260 million enterprise contract for a 2,304-GPU NVIDIA B300 deployment, CEO will join national broadcast outlets to discuss Axe Compute's neocloud AI infrastructure platform
FibroBiologics Announces Release of CYWC628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical TrialHOUSTON, May 04, 2026 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced the release of the first batch of its CYWC628 drug product to support its Phase 1/2 clinical trial in patients with diabetic foot ulcers (DFUs).
DeFi Development Corp. Launches $200 Million At-The-Market Facility (ATM) to Buy More SOLBOCA RATON, FL, May 04, 2026 (GLOBE NEWSWIRE) -- DeFi Development Corp. (Nasdaq: DFDV) (the “Company”), the first US public company with a treasury strategy built to accumulate and compound Solana (“SOL”), today announced a $200 million at-the-market equity program.
SLNO Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, May 04, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Soleno Therapeutics, Inc. (“Soleno” or “the Company”) (
NASDAQ: SLNO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Lexitas CEO Nishat Mehta to Speak on AI in Litigation Support at 2026 ONE Houlihan Lokey Global ConferenceLexitas CEO to join industry leaders for panel discussion on the impact of AI across litigation support services
Premier Truck Rental Expands Rental Offerings with Four New Fleet SolutionsFort Wayne, IN, May 04, 2026 (GLOBE NEWSWIRE) -- Premier Truck Rental (PTR), a nationwide custom truck, trailer and equipment provider, is proud to announce the addition of multiple new products to its portfolio, further strengthening its ability to serve customers in the utilities and construction markets.
Bombardier Announces Launch of US$500,000,000 New Issuance of Senior Notes due 2035 to retire Senior Notes due 2029MONTREAL, May 04, 2026 (GLOBE NEWSWIRE) -- Bombardier Inc. (“Bombardier”) today announced that it has launched an offering of US$500,000,000 aggregate principal amount of new Senior Notes due 2035 (the “New Notes”).Bombardier intends to use the proceeds of the offering of the New Notes, together with cash on hand, (i) to fund the repayment and/or retirement of outstanding indebtedness, including the redemption of all of its outstanding 7.50% Senior Notes due 2029 (the “2029 Notes”, and such redemption, the “Conditional 2029 Notes Redemption”), and (ii) to pay accrued interest and related fees and expenses. As of the date hereof, there is US$750,000,000 aggregate principal amount outstanding of the 2029 Notes.Consummation of the offering of the New Notes and the Conditional 2029 Notes Redemption are subject to market and other conditions, and there can be no assurance that Bombardier will be able to successfully complete these transactions on the terms described above, or at all. The Conditional 2029 Notes Redemption is expected to be subject to certain conditions, including the completion of the offering of the New Notes.This press release does not constitute an offer to sell or buy or the solicitation of an offer to buy or sell any security and shall not constitute an offer, solicitation, sale or purchase of any securities in any jurisdiction in which such offering, solicitation, sale or purchase would be unlawful.The securities mentioned herein have not been and will not be registered under the United States Securities Act of 1933, as amended, any state securities laws or the laws of any other jurisdiction, and may not be offered or sold in the United States absent registration or an applicable exemption from such registration requirements. The securities mentioned herein may be offered and sold in the United States only to persons reasonably believed to be qualified institutional buyers in accordance with Rule 144A under the U.S. Securities Act and outside the United States in reliance on Regulation S under the U.S. Securities Act. The securities mentioned herein have not been and will not be qualified for distribution to the public under applicable Canadian securities laws and, accordingly, any offer and sale of the securities in Canada will be made on a basis which is exempt from the prospectus requirements of such securities laws. The securities will be offered and sold in Canada on a private placement basis only to “accredited investors” pursuant to certain prospectus exemptions.This announcement does not constitute an offer to sell or the solicitation of an offer to buy the New Notes or an offer to purchase or solicitation of an offer to sell the 2029 Notes. This announcement does not constitute a redemption notice in respect of any 2029 Notes. Any redemption of the 2029 Notes will be made pursuant to a notice of redemption under the indenture governing such notes.
Bombardier Announces Conditional Notice of Redemption for All Outstanding 7.50% Senior Notes due 2029MONTREAL, May 04, 2026 (GLOBE NEWSWIRE) -- Bombardier Inc. (“Bombardier”) today announced that it has issued a conditional notice of redemption (the “Notice of Redemption”) for all of its outstanding 7.50% Senior Notes due 2029, in an aggregate principal amount of US$750,000,000 (the “2029 Notes”). As set forth in the Notice of Redemption, the redemption date is May 19, 2026, and the redemption price for the 2029 Notes is 103.750% of the principal amount redeemed, plus accrued and unpaid interest. The redemption of the 2029 Notes is subject to and conditioned upon Bombardier completing a new offering of debt securities in the aggregate principal amount of not less than US$500,000,000 before the May 19, 2026 redemption date (the “New Notes”); however, Bombardier may delay or waive this condition in its sole and absolute discretion. This debt redemption will be paid using proceeds from a New Notes offering and cash from Bombardier’s balance sheet.
L’Oréal and Adeia Enter Multi-Year License AgreementSAN JOSE, Calif., May 04, 2026 (GLOBE NEWSWIRE) -- Adeia Inc. (Nasdaq: ADEA), the technology company known for developing foundational innovations that enable next-generation solutions for the semiconductor and media industries, today announced it has entered into a multi-year license agreement with L’Oréal for access to Adeia’s comprehensive media intellectual property (IP) portfolio.
Serefin Health Launches MyCareSteps Program to Support Care Coordination Across Grey BruceOWEN SOUND, Ontario, May 04, 2026 (GLOBE NEWSWIRE) -- Serefin Health, in partnership with Brightshores Health System and the Grey-Bruce Ontario Health Team (OHT), today announced the launch of MyCareSteps, a proof-of-concept program, to support care coordination for residents across Grey and Bruce counties and to inform future approaches to coordinated care delivery.
Candel Therapeutics to Host Investor Conference Call Following Presentation of Extended Data from Phase 3 Trial of Aglatimagene Besadenovec in Localized Prostate Cancer at the American Urological Association 2026 Annual MeetingNEEDHAM, Mass., May 04, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal immunotherapies to improve outcomes for patients with cancer, today announced that Candel’s management will host a webcast and conference call on Friday, May 15, 2026 at 1:00 PM ET. The call will discuss the Company’s extended follow-up data from the phase 3 clinical trial of aglatimagene besadenovec (aglatimagene or CAN-2409) in patients with intermediate- to high-risk localized prostate cancer. The discussion will follow the oral plenary presentation of these data by Mark G. Garzatto, M.D., Professor of Urology at Oregon Health & Science University and the Portland VA Medical Center, at the American Urological Association (AUA) 2026 Annual Meeting.
Safe Pro Launches New Growth Team Led by Brian Mack as Chief Growth Officer and Benjamin Chitty as VP of Government GrowthAccomplished Acquisition Team of U.S. Army, SOCOM and Former Anduril Executive to Accelerate U.S. Government Growth, Contract Wins and Prime Contractor Partnerships
Recludix Pharma Announces Upcoming Oral Presentations on Preclinical Data for Oral STAT6 Inhibitor REX-8756 and Topical STAT 1/3 Inhibitors at the Society for Investigative Dermatology (SID) Annual MeetingSAN DIEGO, May 04, 2026 (GLOBE NEWSWIRE) -- Recludix Pharma, a clinical-stage company leading the discovery and development of inhibitors of challenging targets for inflammatory disease, today announced preclinical data for STAT6 inhibitor REX-8756 and STAT1/3 inhibitors will be highlighted in two oral presentations at the Society for Investigative Dermatology (SID) Annual Meeting taking place May 13-16, 2026, in Chicago, IL. REX-8756 is an oral, potent and selective STAT6 inhibitor being evaluated in an ongoing blinded, placebo-controlled Phase 1 clinical study.
4DMT to Participate in Upcoming Investor ConferencesEMERYVILLE, Calif., May 04, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today announced that management will present and participate in one-on-one meetings at upcoming investor conferences in May.
Mint Incorporation Limited Announces 1-for-10 Reverse Stock SplitHong Kong, May 04, 2026 (GLOBE NEWSWIRE) -- Mint Incorporation Limited (“Mint” or the “Company”, NASDAQ: MIMI), a Hong Kong-based company with a new strategic focus on artificial intelligence (AI) and robotics, and an established business interior design and fit-out works provider, announces that it is implementing a reverse stock split of all of the Company's issued and unissued shares, including the Class A ordinary shares with no par value (the "Class A Ordinary Shares") and Class B ordinary shares with no par value (the “Class B Ordinary Shares,” together with the Class A Ordinary Shares, the "Ordinary Shares"), at an exchange ratio of one (1) share for ten (10) shares (the “Reverse Stock Split”). The Reverse Stock Split was approved by the Company’s Board of Directors on March 31, 2026.
CPTx to present preclinical proof-of-principle of its DNA-based in vivo CAR T platform at ASGCT Annual MeetingOral presentation includes early readouts from preclinical testing of CAR-encoding episomal DNA delivered by targeted lipid nanoparticles
Rocket Doctor AI Reports Strong 2025 Results, Validating Physician-Led Model with Key U.S. Payer Contracts and AI InnovationVancouver, BC , May 04, 2026 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI” or the “Company”), a physician-built, AI-powered healthcare technology company focused on empowering doctors and expanding access to high-quality care, is pleased to announce that it has filed its audited annual financial statements for the fiscal year and fourth quarter ended December 31, 2025. The Company’s financial statements and Management’s Discussion and Analysis (“MD&A”) are available under its profile on SEDAR+ at www.sedarplus.ca.
Zoom Recognizes the Rise of AI-Powered Businesses of One with Inaugural Solopreneur 50New recognition program and proprietary research highlight how solopreneurs are using AI to replace traditional team functions and build scalable, independent businesses
Rhythm Pharmaceuticals Announces New Data Presentations in Acquired Hypothalamic Obesity at Pediatric Endocrine Society-- Pediatric patients (n=10) with acquired hypothalamic obesity achieved sustained reductions in BMI and BMI-Z at 2.5 years of setmelanotide therapy ---- Weight category improvements observed in pediatric patients with acquired hypothalamic obesity treated with setmelanotide --
Ahold Delhaize USA Brands Expand On-Demand Grocery Delivery with Uber EatsAhold Delhaize USA Brands’ Nearly 2,000 stores Now Available on Uber Eats Marketplace for On-Demand Delivery
Atsena Presents Positive Interim Six-Month Results from Part B of Phase 1/2/3 LIGHTHOUSE Trial Evaluating ATSN-201 in Patients with X-linked RetinoschisisSix-month data from adult Cohort 4 show structural and functional improvements and a favorable safety profile; early safety data from pediatric Cohort 5 are consistent with adult cohorts
Senseonics Enters Into Amended Loan Agreement with Hercules to Increase Borrowing Capacity to $140 MillionGERMANTOWN, Md., May 04, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (
NASDAQ: SENS) a medical technology company focused on the design, development and commercialization of glucose monitoring products designed to transform lives in the global diabetes community, announced that it has entered into a Second Amendment to the Loan and Security Agreement with Hercules Capital, Inc. (
NYSE: HTGC). The Second Amendment increases the maximum borrowing capacity under the existing facility from $100 million to $140 million.
Zyter Launches Praxis, an AI Engine for Executing End-to-end Enterprise WorkflowsPraxis executes complete, AI-powered workflows end-to-end, turning enterprise operations into a self-improving intelligence engine.
U.S. Department of Energy–Funded Study Supports General Fusion’s Fuel Cycle DesignPeer-reviewed research by General Fusion and Savannah River National Laboratory supports the tritium supply advantages of General Fusion’s practical Magnetized Target Fusion technology
Kyverna Therapeutics Appoints Nadia Dac, Seasoned Commercial Leader in Neurology and Rare Disease, as Chief Commercial Officer Ms. Dac brings more than 30 years of experience successfully executing product launches and scaling commercial organizations for a range of therapeutic areas
Legend Biotech Expands Scientific Advisory Expertise to Inform Future GrowthLeading experts across cell therapy, oncology, and immunology will provide strategic input as Legend advances and expands beyond its current portfolio
Apollo Closes Accord Fund VII at $1.9 BillionBrings Total Capital Raised Across Accord Dislocation Complex to $11.6 Billion Since Inception
ProQR Announces Annual General Meeting of Shareholders to be Held June 2, 2026LEIDEN, Netherlands & CAMBRIDGE, Mass., May 04, 2026 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a clinical-stage company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer™ RNA editing technology platform, today announced the Annual General Meeting (AGM) of Shareholders will take place on Tuesday, June 2, 2026 at 1500 CEST at the offices of Allen Overy Shearman Sterling LLP, in Amsterdam, the Netherlands.
May the Force of Giving Be with You to Create a New Hope for AmericaGrapevine, TX, May 04, 2026 (GLOBE NEWSWIRE) -- This May the Fourth, popularly called Star Wars Day, Patriot Mobile is calling on Americans to “use the Force” for good – announcing its growth as a company is enabling an even greater commitment to supporting faith, family, and freedom-focused initiatives nationwide.
